Question 1

How many shares of CERE does BAKER BROS. ADVISORS LP own?

Accepted Answer

BAKER BROS. ADVISORS LP previously held 0 shares of CERE (CEREVEL THERAPEUTICS HLDNG I) before exiting the position in 2024-Q3.

Question 2

What is BAKER BROS. ADVISORS LP's CERE position worth?

Accepted Answer

BAKER BROS. ADVISORS LP's CERE position was last reported at $0 in 2024-Q3 before the exit.

Question 3

Is BAKER BROS. ADVISORS LP buying or selling CERE?

Accepted Answer

In 2024-Q3, BAKER BROS. ADVISORS LP exited their CERE position entirely (-100.0% change in shares).

Question 4

When did BAKER BROS. ADVISORS LP first buy CERE?

Accepted Answer

Based on available 13F filings, BAKER BROS. ADVISORS LP first reported a position in CERE in 2023-Q4. They have held the position across 4 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q2	Decreased	683,588	-57.3%	$28M	0.4%	—	0
2024-Q1	Unchanged	1.6M	0.0%	$67.6M	0.8%	—	0
2023-Q4	New	1.6M	-	$67.8M	0.8%	—	58

CERE4 quarters

CERE
4 quarters